Daily as of 3 Nov 16:00 ET
- Price
- between the two $4.27 vs 50 $3.82 / 200 $5.36
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 1 Sep 2026 · projected 3 bars out
RLMD | Relmada TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$4.27
+$0.43 (+11.20%)
Relmada Therapeutics (RLMD) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $3.58 vs 50 $5.14 / 200 $3.19
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 22 Jun 2026 · projected 28 bars out · tested 1 bar
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $4.15 vs 50 $3.40 / 200 $4.77
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 14 Jul 2026 bar 1 · projected 19 bars out · tested 1 bar
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 1 Sep 2026 | 💀Death steep | daily | 3 bars out | Not tested |
| 14 Jul 2026 | 💀Death | 4-hour | 19 bars out | 1 bar cross test |
| week of 22 Jun 2026 | 🟨Golden steep | weekly | 28 bars out | 1 bar cross test |
| 3 Sep 2025 | 🟨Golden flat | daily | 26 bars out | Not tested |
| 5 May 2025 | 🟨Golden | 4-hour | 8 bars out | — |
About RLMD
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$4.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandsmall